Neutrophils promote experimental choroidal neovascularization.

PURPOSE To investigate the role of neutrophils in the development of laser induced experimental choroidal neovascularization (CNV). METHODS CNV was induced by laser photocoagulation in adult male C57BL/6J mice. Neutrophil infiltration was evaluated by histology and confocal immunohistology. The expression of neutrophil chemotactic chemokines in the regions of laser injury was determined by quantitative real-time PCR. Animals were treated with NIMP-R14, an anti-murine neutrophil monoclonal antibody (mAb), intraperitoneally to deplete neutrophils. The specific neutrophil depletion was confirmed by flow cytometry. The CNV responses were compared between neutropenic and untreated control mice on the basis of fluorescein angiography (FA), CNV lesion volume and lesion histology, and vascular endothelial growth factor (VEGF) expression by ELISA. Expression of VEGF and Angiopoietin-1 and Angiopoietin-2 protein by murine neutrophils was evaluated by confocal immunohistochemistry. RESULTS Neutrophils infiltrated the sites of laser injury as early as day 1 after laser treatment and peaked at day 3. The neutrophil infiltration correlated with enhanced mRNA expression of neutrophil chemotactic chemokines MIP-2 and KC in the lesions. Administration of NIMP-R14 mAb specifically depleted neutrophils. Analysis of FA, CNV volume, and lesion histology, all demonstrated a moderate decrease in the CNV response in neutropenic mice compared to control mice (p<0.01). The reduction in the CNV response in neutropenic mice was associated with decreased VEGF protein levels in the ocular posterior segment. Murine neutrophils contained VEGF and Angiopoietin-1 and Angiopoietin-2 proteins. CONCLUSIONS Neutrophil invasion was part of early inflammatory responses during laser induced CNV. Neutrophil depletion correlated with reduced CNV responses and decreased VEGF protein expression. These data suggest that neutrophils promoted the early development of CNV possibly via secretion of angiogenic growth factors.

[1]  J. Matsuzaki,et al.  Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. , 2003, Cellular immunology.

[2]  Thiennu H. Vu,et al.  Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.

[3]  P Sternberg,et al.  Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. , 1992, American journal of ophthalmology.

[4]  P. Rieu,et al.  Neutrophils: Molecules, Functions and Pathophysiological Aspects , 2000, Laboratory Investigation.

[5]  W R Green,et al.  Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.

[6]  W. Shen,et al.  Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. , 2000, Current eye research.

[7]  J. Lim,et al.  Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. , 2001, Investigative ophthalmology & visual science.

[8]  M. Bergeron,et al.  Role of Chemokines and Formyl Peptides in Pneumococcal Pneumonia-Induced Monocyte/Macrophage Recruitment2 , 2001, The Journal of Immunology.

[9]  C. Greven,et al.  PHOTOCOAGULATION OF WELL‐DEFINED CHOROIDAL NEOVASCULARIZATION IN AGE‐RELATED MACULAR DEGENERATION:Clinicopathologic Correlation , 1998, Retina.

[10]  R P Danis,et al.  Age-related macular degeneration: a review of experimental treatments. , 1998, Survey of ophthalmology.

[11]  Carine Munaut,et al.  Matrix metalloproteinase-9 contributes to choroidal neovascularization. , 2002, The American journal of pathology.

[12]  F. Shi,et al.  Neutralization of Macrophage Inflammatory Protein 2 (MIP-2) and MIP-1α Attenuates Neutrophil Recruitment in the Central Nervous System during Experimental Bacterial Meningitis , 1999, Infection and Immunity.

[13]  G. Lutty,et al.  Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. , 1997, The American journal of pathology.

[14]  S. Edwards,et al.  BCL‐2 family expression in human neutrophils during delayed and accelerated apoptosis , 2001, Journal of leukocyte biology.

[15]  W. Anderson,et al.  Retrovirus-mediated gene transfer to photocoagulation-induced choroidal neovascular membranes. , 1998, Investigative ophthalmology & visual science.

[16]  Bernd Kirchhof,et al.  The FASEB Journal express article 10.1096/fj.02-0157fje. Published online November 15, 2002. Suppression of Fas-FasL-induced endothelial cell apoptosis , 2022 .

[17]  P. Campochiaro,et al.  VEGF is major stimulator in model of choroidal neovascularization. , 2000, Investigative ophthalmology & visual science.

[18]  Bao Lu,et al.  Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice , 2004, Journal of leukocyte biology.

[19]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[20]  P. Penfold,et al.  Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  D. Hinton,et al.  Neutrophils Promote Mononuclear Cell Infiltration During Viral-Induced Encephalitis1 , 2003, The Journal of Immunology.

[22]  K. Sonoda,et al.  The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation , 2004, British Journal of Ophthalmology.

[23]  Rainer M. Bohle,et al.  Real-time quantitative RT–PCR after laser-assisted cell picking , 1998, Nature Medicine.

[24]  T. Dawber,et al.  Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. , 1978, American journal of ophthalmology.

[25]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[26]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[27]  S. Ryan,et al.  Argon Laser Lesions of the Retina; Occurence and Origin of Macrophages , 1992, European journal of ophthalmology.

[28]  K. Fukatsu,et al.  Malnutrition impairs CD11b/CD18 expression on circulating polymorphonuclear neutrophils and subsequent exudation into inflammatory sites in the early phase of glycogen-induced murine peritonitis. , 2000, JPEN. Journal of parenteral and enteral nutrition.

[29]  D. Noonan,et al.  Neutrophils and angiogenesis: potential initiators of the angiogenic cascade. , 2003, Chemical immunology and allergy.

[30]  T. Hisatomi,et al.  The critical role of ocular‐infiltrating macrophages in the development of choroidal neovascularization , 2003, Journal of leukocyte biology.

[31]  H. Agostini,et al.  Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  M. Strath,et al.  Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies , 1984, British journal of haematology.

[33]  R. Danis,et al.  Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration , 2002, The British journal of ophthalmology.

[34]  J. Wang,et al.  Activated human neutrophils release hepatocyte growth factor/scatter factor. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  M. Killingsworth,et al.  Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.

[36]  K. Csaky,et al.  Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[37]  Z. Bian,et al.  Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. , 2004, Investigative ophthalmology & visual science.

[38]  J. Alexander,et al.  The effects of cytokines, platelet activating factor, and arachidonate metabolites on C3b receptor (CR1, CD35) expression and phagocytosis by neutrophils. , 1990, Cytokine.

[39]  F. Calzetti,et al.  On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). , 1999, Journal of immunological methods.

[40]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[41]  D. Eliott,et al.  Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.

[42]  R. Ali,et al.  Gene therapy for ocular angiogenesis. , 2003, Clinical science.

[43]  D. Hinton,et al.  Expression of Matrix Metalloproteinases and Their Tissue Inhibitor during Viral Encephalitis , 2005, Journal of Virology.

[44]  A. Richmond,et al.  Delayed wound healing in CXCR2 knockout mice. , 2000, The Journal of investigative dermatology.

[45]  J. Folkman,et al.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. , 1993, Biochemical and biophysical research communications.

[46]  Y. Ogura,et al.  Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease , 2003, Nature Medicine.

[47]  Ji Ming Wang,et al.  Granulocyte chemotactic protein‐2 and related CXC chemokines: from gene regulation to receptor usage , 1997, Journal of leukocyte biology.

[48]  N. Bressler,et al.  The grading and prevalence of macular degeneration in Chesapeake Bay watermen. , 1989, Archives of ophthalmology.

[49]  Inge Nelissen,et al.  Gelatinase B functions as regulator and effector in leukocyte biology , 2001, Journal of leukocyte biology.

[50]  Joan W. Miller,et al.  VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization , 2003, The Journal of experimental medicine.

[51]  A. Lentsch,et al.  Cytokine and adhesion molecule requirements for neutrophil recruitment during glycogen-induced peritonitis , 1998, Inflammation Research.

[52]  B W Henderson,et al.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.

[53]  E. García-Ramallo,et al.  Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation , 2002, The Journal of Immunology.

[54]  T. Ishibashi,et al.  Pathogenesis of laser-induced choroidal subretinal neovascularization. , 1990, Investigative ophthalmology & visual science.

[55]  A. Adamis,et al.  Ocular neovascularization: an epidemiologic review. , 1998, Survey of ophthalmology.

[56]  D. Noonan,et al.  CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A1 , 2004, The Journal of Immunology.

[57]  S. Yoshida,et al.  Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. , 1998, Investigative ophthalmology & visual science.

[58]  Joan W. Miller,et al.  Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. , 2002, Archives of ophthalmology.

[59]  J. Favier,et al.  Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. , 2005, Blood.

[60]  S. Ryan,et al.  Subretinal neovascularization. Natural history of an experimental model. , 1982, Archives of ophthalmology.

[61]  P. McGuire,et al.  Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition , 2003, Progress in Retinal and Eye Research.

[62]  C. K. Chan,et al.  Systemically expressed soluble Tie2 inhibits intraocular neovascularization. , 2001, Human gene therapy.

[63]  G. Lutty,et al.  Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. , 1998, Archives of ophthalmology.

[64]  Y. Belkaid,et al.  An Immunomodulatory Function for Neutrophils During the Induction of a CD4+ Th2 Response in BALB/c Mice Infected with Leishmania major1 , 2000, The Journal of Immunology.

[65]  M. Burdick,et al.  The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 , 2000, The Journal of Immunology.

[66]  R P Danis,et al.  Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration , 2004, British Journal of Ophthalmology.

[67]  R. D'Amato,et al.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. , 2001, The American journal of pathology.

[68]  W. Gong,et al.  Phenotypic and functional change of cytokine‐activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses , 2001, Journal of leukocyte biology.

[69]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[70]  J. El Benna,et al.  Intracellular pool of vascular endothelial growth factor in human neutrophils. , 1997, Blood.

[71]  Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.

[72]  J. Singer,et al.  Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. , 1993, Blood.